In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice. [electronic resource]
Producer: 20070226Description: 911-20 p. digitalISSN:- 0253-6269
- Administration, Oral
- Animals
- Antioxidants -- administration & dosage
- Area Under Curve
- Biological Availability
- Biological Transport -- drug effects
- Butylated Hydroxyanisole -- administration & dosage
- Chromatography, High Pressure Liquid -- methods
- Gene Expression Regulation, Enzymologic -- drug effects
- Glucuronosyltransferase -- genetics
- Half-Life
- Inactivation, Metabolic -- genetics
- Injections, Intravenous
- Liver -- drug effects
- MAP Kinase Signaling System -- drug effects
- Membrane Transport Proteins -- genetics
- Mice
- Multidrug Resistance-Associated Proteins -- genetics
- NAD(P)H Dehydrogenase (Quinone)
- NADPH Dehydrogenase -- genetics
- Reverse Transcriptase Polymerase Chain Reaction -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.